Field A

Field A. All oral and intravenous applications of [**] in the treatment of [**] conditions (including, without limitation, [**](including, without limitation, [**] (including, without limitation, [**] (including, without limitation, [**]).

Field A. All oral and intravenous applications of [**] Inhibitors in the treatment of diarrhea, impotence, brain edema/swelling, memory loss (excluding that associated with Alzheimer's disease), vascular conditions (including, without limitation, periphral vascular disease), Raynaud's phenomenon, cerebral and coronary vascular spasm, arrhythmias, muscle disease (including, without limitation, myotonia and wasting), respiratory disease (including, without limitation, COPD and cystic fibrosis) and renal... conditions (including, without limitation, diuretics for water overload and with activity in kidney failure). View More

Field A. All Products, Methods of Manufacture and Methods of Use Thereof for all STASIS, ADHESION AND BARRIER APPLICATIONS, but specifically excluding CELLULAR DELIVERY